BeOne’s sonrotoclax gains priority FDA review for mantle cell lymphoma
The application is based on data from a global, open-label, multicentre Phase I/II study.
Drug Development
Corstasis Therapeutics partners CVL for Enbumyst integration
UNICEF and Gavi to widen affordable malaria vaccine access
FDA grants accelerated approval for Otsuka’s IgAN therapy
Novartis secures approval from FDA for Itvisma to treat SMA
FDA awards record number of review designations to ADCs in 2024
AstraZeneca to expand biomanufacturing in Maryland, US
Vaximm and BCME link on oral cancer immunotherapy platform
